Vestal Point Capital’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-490,000	Closed	-$1.59M	–	89
2024 Q3	$1.59M	Sell	490,000 -710,000	-59%	-$2.3M	0.12%	62
2024 Q2	$3.6M	Hold	1,200,000	–	–	0.27%	48
2024 Q1	$5.58M	Buy	1,200,000 +1,085,000	+943%	+$5.05M	0.46%	43
2023 Q4	$476K	Buy	+115,000	New	+$476K	0.05%	43